Diagnostic methods for intracellular pathogens

Clinical Microbiology and Infection

Volumn 1, Issue SUPPL. 1, 1996, Pages

  Hammerschlag, Margaret R ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Chlamydia pneumoniae; Culture; PCR; Respiratory infection; Serology

Indexed keywords

EID: 0002046179     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1996.tb00582.x     Document Type: Article

References (36)

1. Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161: 618-25.
2. Grayston JT, Aldous MB, Easton A, et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 1993; 168: 1231-5.
3. Chirgwin K, Roblin PM, Gelling M, Hammerschlag MR, Schachter J. Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis 1991; 163: 757-61.
4. Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 1995; 14: 471-7.
5. Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994; 148: 727-32.
6. Hammerschlag MR, Chirgwin K, Roblin PM, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992; 14: 178-82.
7. Kuo CC, Shor A, Campbell LA, Fukushi H, Patron DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841-9.
8. Kuo CC, Grayston JT. Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR. J Clin Microbiol 1988; 26: 812-15.
9. Cles LD, Stamm W. Use of HL cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 1990; 28: 938-40.
10. Kuo CC, Grayston JT. A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 162: 755-8.
11. Wong KH, Skelton SK, Chan YK. Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract. J Clin Microbiol 1992; 30: 1625-30.
12. Roblin PM, Dumomay W, Hammerschlag MR. Use of Hep-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 1992; 30: 1968-71.
13. Maass M, Harig U. Evaluation of culture conditions used for isolation of Chlamydia pneumoniae. Am J Clin Pathol 1995; 103: 141-8.
14. Montalban GS, Roblin PM, Hammerschlag MR. Performance of three commercially available monoclonal reagents for confirmation of Chlamydia pneumoniae in cell culture. J Clin Microbiol 1994; 32: 1406-7.
15. Augenbraun MH, Roblin PM, Chirgwin K, Landman D, Hammerschlag MR. Isolation of Chlamydia pneumoniae from the lungs of patients infected with the human immunodeficiency virus. J Clin Microbiol 1991; 29: 401-2.
16. Augenbraun MH, Roblin PM, Mandel LJ, Hammerschlag MR. Chlamydia pneumoniae pneumonia with pleural effusion: diagnosis by culture. Am J Med 1991; 91: 437-8.
17. Verkooyen RP, Hazenberg MA, Van Haaren GH, et al. Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor. J Clin Microbiol 1992; 30: 1287-90.
18. Bardel BP, Fields PI, Melbye H. Chlamydia pneumonia respiratory tract infection: the interpretation of high titers in the complement fixation test. Scand J Infect Dis 1991; 23 305-7.
19. Pether JVS, Wang SP, Grayston JT. Chlamydia pneumoniae strain TWAR, as the cause of an outbreak in a boys' school previously called psittacosis. Epidemiol Infect 1989; 103: 395-400.
20. Fryden A, Kihlstrom E, Maller R, Persson K, Romanus V, Ansehn S. A clinical and epidemiological study of 'omithosis' caused by Chlamydia psittaci and Chlamydia pneumoniae (strain TWAR). Scand J Infect Dis 1989; 21: 681-91.
21. Bruu AL, Haukenes G, Aasen S, et al. Chlamydia pneumoniae infections in Norway 1981-87 earlier diagnosed as ornithosis. Scand J Infect Dis 1991; 23: 299-304.
22. Kern DG, Neill MA, Schachter J. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Chest 1993; 104: 208-13.
23. Hyman CL, Roblin PM, Gaydos CA, Quinn TC, Schachter J, Hammerschlag MR. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 1995; 20: 1174-8.
24. Carter MW, Al-Mahdawi SAH, Giles IG, Treharne JD, Ward ME, Clarke IN. Nucleotide sequence and taxonomic value of the major outer membrane protein gene of Chlamydia pneumoniae IOL-207. J Gen Microbiol 1991; 137: 465-75.
25. Campbell LA, Kuo CC, Wang SP, Grayston JT. Serological response to Chlamydia pneumoniae infection. J Clin Microbiol 1990; 28: 1261-4.
26. Black CM, Johnson JE, Farshy CE, Brown TM, Berdal BP. Antigenic variation among strains of Chlamydia pneumoniae. J Clin Microbiol 1991; 29: 1312-16.
27. Iljima Y, Miyashita N, Kishimoto T, Kanamoto Y, Soejima R, Matsumoto A. Characterization of Chlamydia pneumoniae species-specific proteins immuno-dominant in humans. J Clin Microbiol 1994; 32: 583-8.
28. Ozanne G, Lefebvre J. Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections. Can J Microbiol 1992; 38: 1185-9.
29. Gonen R, Shemer-Avni Y, Csango PA, Serov B, Friedman MG. Serum reactivity to Chlamydia trachomatis and C. pneumoniae antigens in patients with documented infection and in healthy children by microimmunofluorescence and immunoblotting techniques. APMIS 1993; 101: 719-26.
30. Roblin PM, Dumomay W, Emre U, Rank RG, Hammerschlag MR. Serologic response to Chlamydia pneumoniae infection in children [abstract G40]. Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1994: 43.
31. Moss TR, Darougar S, Woodland RM, Nathan M, Dines RJ, Cathrine V. Antibodies to Chlamydia species in patients attending a genitourinary clinic and the impact of antibodies to C. pneumoniae and C. psittaci on the sensitivity and the specificity of C. trachomatis serology tests. Sex Transmit Dis 1993; 20: 61-5.
32. Porder K, Sanchez N, Roblin PM, McHugh M, Hammerschlag MR. Lack of specificity of Chlamydiazyme for detection of vaginal chlamydial infection in prepubertal girls. J Pediatr Infect Dis 1989; 8: 359-60.
33. Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986; 315: 161-8.
34. Campbell LA, Melgosa MP, Hamilton DJ, Kuo CC, Grayston JT. Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol 1992; 30: 434-9.
35. Gaydos CA, Quinn TC, Eiden JJ. Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene. J Clin Microbiol 1992; 30: 769-800.
36. Gaydos CA, Roblin PM, Hammerschlag MR, et al. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 1994; 32: 903-5.